Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Boehringer Ingelheim signs retinal disease deal with Inflammasome
Image: Boehringer Ingelheim partners with Inflammasome Therapeutics to develop drugs for retinal drugs. Photo: courtesy of Madras150/Wikimedia Commons.
Image: Boehringer Ingelheim partners with Inflammasome Therapeutics to develop drugs for retinal drugs. Photo: courtesy of Madras150/Wikimedia Commons.